| Year |
Citation |
Score |
| 2017 |
Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemotherapy and Pharmacology. PMID 28233053 DOI: 10.1200/Jco.2015.33.15_Suppl.2029 |
0.311 |
|
| 2016 |
Koshkaryev A, Fitzgerald J, Kim J, Kalra A, Kamoun W, Blanchette S, Luus L, Klinz S, Alkan O, Kornaga T, Bates S, Pommier Y, Drummond DC. Abstract 2075: Differential tissue clearance results in improved therapeutic index for irinotecan liposome injection (ONIVYDE) when combined with the PARP inhibitor veliparib in preclinical cervical tumors Cancer Research. 76: 2075-2075. DOI: 10.1158/1538-7445.Am2016-2075 |
0.314 |
|
| 2014 |
Kalra AV, Kim J, Klinz SG, Paz N, Cain J, Drummond DC, Nielsen UB, Fitzgerald JB. Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion. Cancer Research. 74: 7003-13. PMID 25273092 DOI: 10.1158/0008-5472.Can-14-0572 |
0.344 |
|
| 2014 |
Kalra AV, Spernyak J, Kim J, Sengooba A, Klinz S, Paz N, Cain J, Kamoun W, Straubinger N, Qu Y, Trueman S, Bayever E, Nielsen U, Drummond D, Fitzgerald J, et al. Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI) Cancer Research. 74: 2065-2065. DOI: 10.1158/1538-7445.Am2014-2065 |
0.337 |
|
| 2013 |
Kalra A, Kim J, Klinz S, Paz N, Reutt J, Drummond D, Kirpotin D, Moyo V, Bayever E, Laivins P, Niyikiza C, Nielsen U, Fitzgerald J. Abstract 5622: The tumor microenvironment modulates the delivery and activation of liposomal encapsulated irinotecan, MM-398. Cancer Research. 73: 5622-5622. DOI: 10.1158/1538-7445.Am2013-5622 |
0.366 |
|
| 2013 |
Klinz SG, Zheng J, Souza RD, Dunne M, Cain J, Kim J, Paz N, Kalra A, Jaffray D, Fitzgerald J. Abstract C293: Irinotecan sucrosofate liposome injection, MM-398, demonstrates superior activity and control of hypoxia as measured through longitudinal imaging using [18F]FAZA PET compared to free irinotecan in a colon adenocarcinoma xenograft model. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C293 |
0.348 |
|
| 2012 |
Paz N, Laivins P, Niyikiza C, Nielsen U, Fitzgerald J, Kalra A, Chalishazar M, Klinz S, Kim J, Drummond D, Kirpotin D, Moyo V, Bayever E. Abstract A63: MM-398/PEP02, a novel liposomal formulation of irinotecan, demonstrates stromal-modifying anticancer properties. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A63 |
0.349 |
|
| 2012 |
Kim J, Bayever E, Laivins P, Niyikiza C, Nielsen U, Fitzgerald J, Kalra A, Chalishazar M, Klinz S, Paz N, Hendriks B, Drummond D, Kirpotin D, Moyo V. Abstract A6: Sustained intratumoral activation of MM-398 results in superior activity over irinotecan demonstrated by using a systems pharmacology approach Cancer Research. 72. DOI: 10.1158/1538-7445.Csb12-A6 |
0.379 |
|
| 2012 |
Kalra A, Klinz S, Paz N, Kim J, Chalishazar M, Drummond D, Kirpotin D, Moyo V, Niyikiza C, Fitzgerald J. Abstract 5696: Evaluating determinants for enhanced activity of MM-398/PEP02; a novel nanotherapeutic encapsulation of irinotecan (CPT-11) Cancer Research. 72: 5696-5696. DOI: 10.1158/1538-7445.Am2012-5696 |
0.367 |
|
| 2011 |
Kim J, Saidel GM, Kalhan SC. Regulation of Adipose Tissue Metabolism in Humans: Analysis of Responses to the Hyperinsulinemic-Euglycemic Clamp Experiment. Cellular and Molecular Bioengineering. 4: 281-301. PMID 23646067 DOI: 10.1007/S12195-011-0162-2 |
0.579 |
|
| 2011 |
Klinz SG, Paz N, Kalra A, Kim J, Hendriks B, Drummond D, Kirpotin D, Moyo V, Yeh CG, Niyikiza C, Fitzgerald J. Abstract C207: Identifying differential mechanisms of action for MM-398/PEP02, a novel nanotherapeutic encapsulation of irinotecan. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C207 |
0.35 |
|
| 2009 |
Li Y, Dash RK, Kim J, Saidel GM, Cabrera ME. Role of NADH/NAD+ transport activity and glycogen store on skeletal muscle energy metabolism during exercise: in silico studies. American Journal of Physiology. Cell Physiology. 296: C25-46. PMID 18829894 DOI: 10.1152/Ajpcell.00094.2008 |
0.586 |
|
| 2008 |
Nye C, Kim J, Kalhan SC, Hanson RW. Reassessing triglyceride synthesis in adipose tissue Trends in Endocrinology and Metabolism. 19: 356-361. PMID 18929494 DOI: 10.1016/J.Tem.2008.08.003 |
0.392 |
|
| 2008 |
Dash RK, Li Y, Kim J, Beard DA, Saidel GM, Cabrera ME. Metabolic dynamics in skeletal muscle during acute reduction in blood flow and oxygen supply to mitochondria: in-silico studies using a multi-scale, top-down integrated model. Plos One. 3: e3168. PMID 18779864 DOI: 10.1371/Journal.Pone.0003168 |
0.619 |
|
| 2008 |
Dash RK, Li Y, Kim J, Saidel GM, Cabrera ME. Modeling cellular metabolism and energetics in skeletal muscle: large-scale parameter estimation and sensitivity analysis. Ieee Transactions On Bio-Medical Engineering. 55: 1298-318. PMID 18390321 DOI: 10.1109/Tbme.2007.913422 |
0.612 |
|
| 2008 |
Kim J, Saidel GM, Kalhan SC. A computational model of adipose tissue metabolism: evidence for intracellular compartmentation and differential activation of lipases. Journal of Theoretical Biology. 251: 523-40. PMID 18234232 DOI: 10.1016/J.Jtbi.2007.12.005 |
0.614 |
|
| 2007 |
Chalhoub E, Xie L, Balasubramanian V, Kim J, Belovich J. A distributed model of carbohydrate transport and metabolism in the liver during rest and high-intensity exercise. Annals of Biomedical Engineering. 35: 474-91. PMID 17151925 DOI: 10.1007/S10439-006-9217-2 |
0.464 |
|
| 2007 |
Kim J, Saidel GM, Cabrera ME. Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control. Annals of Biomedical Engineering. 35: 69-90. PMID 17111212 DOI: 10.1007/S10439-006-9201-X |
0.629 |
|
| 2006 |
Kim J, Saidel GM, Kirwan JP, Cabrera ME. Computational model of glucose homeostasis during exercise. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 1: 311-4. PMID 17946814 DOI: 10.1109/IEMBS.2006.260736 |
0.58 |
|
| Show low-probability matches. |